about
Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiencyPeriodontal disease: linking the primary inflammation to bone lossOsteoporosis and obesity: Role of Wnt pathway in human and murine modelsIL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor.Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor.Skeleton and glucose metabolism: a bone-pancreas loop.FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis.Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia.Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro.Irisin enhances osteoblast differentiation in vitroOsteoclastogenesis and arthritis.Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene.Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.Osteoblasts display different responsiveness to TRAIL-induced apoptosis during their differentiation process.Myeloma cells suppress osteoblasts through sclerostin secretion.Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.Sclerostin is overexpressed by plasma cells from multiple myeloma patients.Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients.A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like cells and future perspectives.Increased osteoclast activity in the presence of increased homocysteine concentrations.The effects of bone pâté on human osteoblasts cell cultures.Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts.Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin.Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia.Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation.Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects.Dental pulp stem cells: osteogenic differentiation and gene expression.Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance.Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation.L: -carnitine fumarate and isovaleryl-L: -carnitine fumarate accelerate the recovery of bone volume/total volume ratio after experimetally induced osteoporosis in pregnant mice.Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome.L-carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro.Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces.Pathology of idiopathic encephaloceles into the middle ear.Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures.Aortic valvular interstitial cells apoptosis and calcification are mediated by TNF-related apoptosis-inducing ligand.High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment.The role of TNF-α and TNF superfamily members in the pathogenesis of calcific aortic valvular disease.Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts.
P50
Q26821908-EFF331F7-9925-4048-A697-DC3E661296C7Q26995381-92852F24-D8C0-441D-8E47-8982E39B292AQ27026535-FF339A55-4520-4CA5-B7B3-49131E7EBF26Q33268293-8E1ADD73-59B5-4B80-B063-E1ACE8DEC124Q33983183-59FDDD5A-38F3-4D08-812A-FB93226DDE21Q34581041-08879BD7-55DD-4F96-9B4B-578F166DBEACQ35250223-08F25992-9379-48B0-8147-3B00389E89EBQ36931382-3776499E-404A-42FF-952C-3F87C4847521Q37319607-DB2F805C-6D43-4492-9036-47C31CC75B97Q37430185-F596F51D-29B5-42C2-A6DE-B1DCFD63EC9AQ37651011-DDEB189B-22B2-44E8-9D52-CEEFAA743565Q37808649-51D03FF7-E024-4E24-95C7-3D1DB9105DE6Q38013655-99E3CC62-CF2B-4FC2-91AA-45E1E3CE8D60Q38298890-3AB32F48-F918-4D2F-80D2-546D29C086AAQ38315460-C6FC0E77-4C7F-4197-8482-93A838AE57B4Q38323256-DD6D7089-A4D3-42E6-A7E8-72288061B220Q38325516-ED4A560F-37BA-41C2-98EF-6C7EA74AE11EQ39443327-5559DC33-F465-47D5-B081-465092BF780CQ39827231-522951ED-861E-4C6B-A67B-BC234D524D6AQ40215753-60BD4B81-49C3-42AB-9C73-7F8A04855D72Q40384790-86028C93-02A4-44BC-91C3-EF910A860337Q40776890-0E89F4BF-9451-46B4-B27F-C5D2C4185A7EQ40885466-33325AB7-7B07-4969-9D32-00979F8FC7ADQ41014825-A92E5B2E-C6D0-4983-9B10-30B6A56059C3Q41980849-54A633EC-C62B-49F1-B419-F0ABED34DE76Q42476279-979F2285-F747-4344-B434-1C2C63809AA0Q42482440-F086EB43-7579-4CAE-B532-70D41FD5A85EQ43449009-3C74DED4-38F4-4C54-A8DE-477619D226FEQ46032998-B2397FB7-56F9-45B3-A521-23075D0AFF96Q46260439-56D80559-32C5-4D21-8D12-22937EFB5065Q46278218-4C12518D-C2A5-4869-8D1E-BCD91DC88E8BQ46280448-99D00F38-EE07-41EA-9628-CEDD8E9130D9Q46283718-641A8ABF-8B05-466F-935F-EF62E0EAB9B6Q47695250-F054E691-3CF7-4587-8D50-10FBA5737584Q48601891-3746695C-9250-4861-BEC7-E9D84295CCCAQ50996242-E8740EBC-34C1-4636-AAA1-1CA0B2C23AEEQ53085645-6EF58762-9EB7-42CE-B2E5-050092FC147EQ54276622-736A0477-C0BE-42F6-8FE4-8C44462E1D55Q54487255-CE553940-B5EC-4D43-BFA6-06809670FAA8Q54575541-E6DA220B-BC4B-4CA3-9A45-F63D20F238AE
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Silvia Colucci
@ast
Silvia Colucci
@en
Silvia Colucci
@es
Silvia Colucci
@nl
Silvia Colucci
@sl
type
label
Silvia Colucci
@ast
Silvia Colucci
@en
Silvia Colucci
@es
Silvia Colucci
@nl
Silvia Colucci
@sl
prefLabel
Silvia Colucci
@ast
Silvia Colucci
@en
Silvia Colucci
@es
Silvia Colucci
@nl
Silvia Colucci
@sl
P106
P1153
7005687297
P21
P31
P496
0000-0001-9970-3539